Navigation Links
Isis Pharmaceuticals Files Patent Infringement Suit Against Santaris Pharma
Date:9/23/2011

tellation of collaborative relationships with large and small companies advancing antisense drugs and the antisense technology platform," said B. Lynne Parshall, COO and CFO of Isis.  "A necessary component of our strategy is that we vigorously pursue infringement of our intellectual property.  The exemption from patent infringement for drug development was created to encourage rapid introduction of generic medicines.  We allege Santaris' activities are not protected by this exemption and that case law affirms our position."  

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 24 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic and severe and rare/neurodegenerative diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, mipomersen, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT

This press release includes forward-looking statements regarding Isis' intellectual property position and its value in drug discovery and development.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of mipomersen, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the end
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Calif. , Sept. 30, 2014 ... of the American Association of Tissue Banks (AATB), ... , Chief Executive Officer. Accreditation follows ... by a specially trained AATB inspector.  It establishes ... performance within the facility meets or exceeds the ...
(Date:9/30/2014)... 30, 2014 The report based ... Size, Share, Growth and Forecast, 2007 - 2017," elaborated ... USD 20.8 billion in 2012 and is further expected ... a CAGR of 7.3% from 2012 to 2017. ... health purposes, especially to prevent chronic diseases that may ...
(Date:9/30/2014)... 2014  The orthopedic specialists at Midwest Orthopaedics ... orthopedic group by US News & World Report, are ... of free, public seminars to discuss partial and total ... come to see the knee physicians at Midwest Orthopaedics ... at Munster Specialty Surgery Center. The ...
Breaking Medicine Technology:Biostructures, LLC Earns AATB Accreditation 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4"Knee Pain Solutions for Active Adults" Complimentary Seminars Open to the Public 2
(Date:9/30/2014)... is no stranger to the children of Tanzania. What ... to clinical services, including reliable diagnosis and evidence-based treatments. ... for use in Swahili, a major language of the ... Brown University and the University of Georgia (UGA) describe ... two sites in the country and found to be ...
(Date:9/30/2014)... September 30, 2014 Integrated Medicine ... is opening another new medical specialty practice through a ... Cardiology will be located within the company’s Shrewsbury ... and Dr. Isaac Tawfik of American Heart Center, P.C., ... new practice will offer Integrated Medicine Alliance patients top ...
(Date:9/30/2014)... 30, 2014 Glycodrive , one ... designed to help maximize lean, strong muscle growth with ... absorption of glucose has caught the attention of Shane ... purpose behind Glycodrive is to help the body use ... Michaels. “Carbs are essential in the muscle-building process, and ...
(Date:9/30/2014)... September 30, 2014 VisitandCare.com ... Turkey has gone up more than 79 percent in ... tourism company also reported total revenue tripled for its ... The company’s professional strategy has allowed them to partner ... designed for patient comfort and privacy — with state-of-the-art ...
(Date:9/30/2014)... A group of Americans is headed to ... that, left unchecked, could create a catastrophic, global pandemic. No, ... Africa. John Rogers, the Executive Director the Eugene Bell Foundation ... a disease most think mankind conquered long ago: tuberculosis. , ... is on the comeback in several countries - what’s especially ...
Breaking Medicine News(10 mins):Health News:New diagnostic approach for autism in Tanzania 2Health News:New diagnostic approach for autism in Tanzania 3Health News:New diagnostic approach for autism in Tanzania 4Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2
... global outbreak of the SWINE FLU and Mexico representing ... combat the continued spread of the unpredictable virus. U.S. ... a Combatant.There is now an outstanding scientific formula to ... TUBERCULOCIDAL AND FUNGICIDE" that is formulated to deal ...
... Program to Launch at the Annual Oncology Nursing Society ... ONS Edge , a subsidiary of the Oncology Nursing ... celebrity make-up artist and cancer survivor Jan Ping to ... From the Outside In . The initiative is aimed ...
... 2009 Biogen Idec (NASDAQ: BIIB) today announced data ... Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) ... Risk Subjects AVONEX MS Prevention Study). Based on ... in patients who experienced their first clinical MS episode ...
... Launches Women of Hope is Beautiful Campaign to Inspire OthersWASHINGTON, ... control, community, caring -- ask any woman who has ... these words. They are also integral to Look ... to help women cope with the appearance-related changes of cancer ...
... Driving Increased Utilization of ePrescribing within Electronic ... Tullman Testifies Before National Committee on Vital ... announced today that, for the second consecutive ... the Surescripts network than any other e-prescribing ...
... residents Access to Nursing Home, Assisted Living, Home Care and ... Statewide RICHMOND, Va., April 30 The cost ... rate outpacing inflation, putting significant financial pressure on those in ... Financial. At the same time, the current economic downturn ...
Cached Medicine News:Health News:USC Chemical Engineer Launches Virucide, Bactericidal That Can Kill 99.9% of Germs and Help Combat Swine Flu 2Health News:Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 2Health News:Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 3Health News:First ten-year follow-up shows that treatment with AVONEX leads to long-term benefits in early multiple sclerosis patients 2Health News:Photos: Look Good. . .Feel Better Celebrates 20 Years of Helping Women Cope With Cancer 2Health News:Photos: Look Good. . .Feel Better Celebrates 20 Years of Helping Women Cope With Cancer 3Health News:Photos: Look Good. . .Feel Better Celebrates 20 Years of Helping Women Cope With Cancer 4Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 2Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 3Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 4Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 5Health News:Allscripts Ranked No. 1 in Electronic Prescription Routing for Second Consecutive Year 6Health News:Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: